FDA increases enforcement actions against devices sector
This article was originally published in Clinica
Executive Summary
The Guidant criminal case was among the top enforcement actions in the US last year, write Jonathan Kahan & Edward C Wilson Jr* of Washington, DC law firm Hogan & Hartson in a review of legal and regulatory issues that confronted the US industry last year